期刊:Japan journal of clinical & medical research [Scientific Research and Community Ltd] 日期:2022-04-06卷期号:: 1-7被引量:1
标识
DOI:10.47363/jjcmr/2022(2)131
摘要
In 2021, the US Food and Drug Administration approved 50 novel drugs. Twenty three of the 50 (46%) drugs were categorized as orphan drug, and 9 of the 50 (18%) were approved under accelerated approval. This review includes a summary of the novel drugs approved by the US Food and Drug Administration in 2021